Efficacy of the GMZ2 malaria vaccine in African children

被引：0
|
作者：
Milligan, Paul [1 ]
Flach, Clare [1 ]
Theisen, Michael [2 ,3 ,4 ]
机构：
[1] London Sch Hyg & Trop Med, London, England
[2] Statens Serum Inst, Dept Congenital Disorders, Artillerivej 5, DK-2300 Copenhagen S, Denmark
[3] Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, DK-1168 Copenhagen, Denmark
[4] Copenhagen Univ Hosp, Dept Infect Dis, Rigshosp, Copenhagen, Denmark
来源：
VACCINE | 2017年 / 35卷 / 02期
基金：
英国医学研究理事会;
关键词：
D O I：
10.1016/j.vaccine.2016.11.016
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：202 / 202
页数：1
相关论文
共 50 条
  • [21] Humoral immune response to Plasmodium falciparum vaccine candidate GMZ2 and its components in populations naturally exposed to seasonal malaria in Ethiopia
    Mamo, Hassen
    Esen, Meral
    Ajua, Anthony
    Theisen, Michael
    Mordmueller, Benjamin
    Petros, Beyene
    MALARIA JOURNAL, 2013, 12
  • [22] Effect of hookworm infection and anthelmintic treatment on naturally acquired antibody responses against the GMZ2 malaria vaccine candidate and constituent antigens
    Amoani, Benjamin
    Gyan, Ben
    Sakyi, Samuel Asamoah
    Abu, Emmanuel Kwasi
    Nuvor, Samuel Victor
    Barnes, Precious
    Sarkodie-Addo, Tracy
    Ahenkorah, Benjamin
    Sewor, Christian
    Dwomoh, Duah
    Theisen, Michael
    Cappello, Michael
    Wilson, Michael D.
    Adu, Bright
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [23] Malariometric indices from Iganga, Uganda: Baseline characterization in preparation of GMZ2 vaccine trial
    Kaddumukasa M.
    Buwembo W.
    Sekikubo M.
    Naiwumbwe H.
    Namusoke F.
    Kiwuwa S.
    Oketch B.
    Noor R.
    Chilengi R.
    Mworozi E.
    Kironde F.
    BMC Research Notes, 7 (1)
  • [24] New malaria vaccine reduces malaria by half in African children
    不详
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2012, 48 (10) : 945 - 945
  • [25] Holistic capacity building through the EDCTP funded GMZ2 consortium
    Okech, B.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 : 64 - 65
  • [26] Studies of new adjuvants and formulations of GMZ2 with the aim to enhance immunogenicity
    Theisen, M.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 : 44 - 44
  • [27] Phase Ib randomised controlled double-blind trial to evaluate the safety and immunogenicity of 30 and 100 μg GMZ2 candidate malaria vaccine in Gabonese children aged 1-5 years
    Issifou, S.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 (08) : S16 - S16
  • [28] Design of a Phase IIb, randomized, controlled, double-blind, multi-centre study to evaluate the efficacy, safety, and immunogenicity of the GMZ2 candidate malaria vaccine in Ugandan, Ghanaian, Burkinabe and Gabonese children aged 12-60 months
    Ramadhani A Noor
    Michael Thiesen
    Benjamin Mordmuller
    Paul Milligan
    Frank Atuguba
    Sodiomon Sirima
    Saadou Issifou
    Kalifa Bojang
    Fred Kironde
    Alfred Tiono
    Brenda Okech
    Roma Chilengi
    Ateba Ngoa
    Kaddu Mukasa
    Soren Jepsen
    Malaria Journal, 9 (Suppl 2)
  • [29] Challenges in carrying out multicentre clinical trials in a consortium: the GMZ2 experience
    Ejigu, D.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 : 44 - 45
  • [30] PRELIMINARY RESULTS OF A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, SINGLE-CENTER PHASE 1 CLINICAL TRIAL TO EVALUATE SAFETY, TOLERABILITY, IMMUNOGENICITY AND EFFICACY OF CAF01 AND ALUMINUM HYDROXIDE AS ADJUVANTS FOR THE MALARIA VACCINE CANDIDATE GMZ2 IN HEALTHY ADULT AFRICAN VOLUNTEERS
    Ngoa, Ulysse Ateba
    Adegnika, Ayola Akim
    Agobe, Jean Claude Dejon
    Massinga-Loembe, Marguerite
    Theisen, Michael
    Kremsner, Peter G.
    Mordmueller, Benjamin
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2015, 93 (04): : 505 - 506
12345